½ÃÀ庸°í¼­
»óǰÄÚµå
1424909

¼¼°èÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, Á¦Á¦º°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Adhesion Barrier Market Size study & Forecast, by Product, by Formulation, by Application and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è À¯Âø ¹æÁöÁ¦ ½ÃÀåÀº 2022³â ¾à 6¾ï 2,161¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È 8.40% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Âø ¹æÁöÁ¦´Â À¯Âø Çü¼ºÀ» ¹æÁöÇϰųª ÁÙÀ̱â À§ÇØ ¼³°èµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. À¯ÂøÀº ±â°üÀ̳ª Á¶Á÷ »çÀÌ¿¡ Çü¼ºµÇ´Â ¼¶À¯Áú ¶ì ¸ð¾çÀÇ Á¶Á÷À¸·Î, Á¾Á¾ ¼ö¼úÀ̳ª ¿Ü»óÀÇ °á°ú·Î ¹ß»ýÇÕ´Ï´Ù. ÀÌ·¯ÇÑ À¯ÂøÀº Àå±â¿Í Á¶Á÷ÀÌ ¼­·Î ´Þ¶óºÙ¾î ÅëÁõ, ÀåÆó»ö ¹× ºÒÀÓ°ú °°Àº ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯Âø ¹æÁöÁ¦´Â ÀÎÁ¢ÇÑ Á¶Á÷ »çÀÌ¿¡ ¹°¸®Àû À庮À» ¸¸µé¾î À¯Âø Çü¼ºÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¼ö¼ú °Ç¼ö Áõ°¡, °í·ÉÈ­ Àα¸ Áõ°¡, ºÎÀΰú ÁúȯÀÇ À¯º´·ü Áõ°¡, °üÀý ġȯ¼ú ¹× ÀÎ´ë ¼öº¹¼úÀ» Æ÷ÇÔÇÑ Á¤Çü¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡·Î 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¼ö¼ú °Ç¼öÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ö¼ú °Ç¼ö°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ¼ö¼ú ÈÄ À¯Âø Çü¼ºÀÇ À§Çèµµ Áõ°¡ÇÕ´Ï´Ù. ¼ö¼ú °Ç¼öÀÇ Áõ°¡´Â À¯ÂøÀ¸·Î ÀÎÇÑ ÇÕº´ÁõÀ» ¿¹¹æÇϱâ À§ÇØ À¯Âø ¹æÁöÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÑ´Ù´Â °ÍÀ» ÀǹÌÇÕ´Ï´Ù. Statista¿¡ µû¸£¸é 2022³â Àü ¼¼°è ¼ö¼ú °Ç¼ö´Â 2¾ï 9,424¸¸ °ÇÀ¸·Î 2025³â¿¡´Â 3¾ï 1,621¸¸ °Ç¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿¡ µû¶ó ¼ö¼ú °Ç¼öÀÇ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í À¯Âø °ü·Ã ÇÕº´Áõ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡´Â 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦¿Í Á¦ÇÑµÈ ±â¼ú Çõ½ÅÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â º¹ºÎ ¼ö¼ú, ºÎÀΰú ¼ö¼ú, Á¤Çü¿Ü°ú ¼ö¼ú µî ¼ö¼ú °Ç¼ö Áõ°¡, º¸´Ù È¿°úÀûÀÌ°í ¿À·¡ Áö¼ÓµÇ´Â À庮ÀÇ ½ÃÀå °³Ã´À» Æ÷ÇÔÇÑ À¯Âø ¹æÁöÁ¦ ±â¼úÀÇ ¹ßÀü, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¹Ý¸é ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¼ö¼ú Áõ°¡, À¯Âø °ü·Ã ÇÕº´Áõ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹® ¹× ±¹°¡º° ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ, ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú µµÀü °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚµéÀÌ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°èÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå ¿ªÇÐ

  • À¯Âø ¹æÁöÁ¦ ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ¿Ü°ú¼ö¼ú °Ç¼ö Áõ°¡
      • °í·ÉÈ­ Àα¸ Áõ°¡
      • ºÎÀΰú Áúȯ Áõ°¡
      • Á¤Çü¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡
    • ½ÃÀå °úÁ¦
      • ¾ö°ÝÇÑ ±ÔÁ¦¿Í ÇÑÁ¤µÈ ±â¼ú Çõ½Å
    • ½ÃÀå ±âȸ
      • ÇコÄɾî ÁöÃâ Áõ°¡
      • À¯Âø °ü·Ã ÇÕº´Áõ¿¡ ´ëÇÑ ÀÎ½Ä È®»ê

Á¦4Àå ¼¼°èÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Á¦Ç°º°, ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ÇÕ¼º À¯Âø ¹æÁöÁ¦
    • õ¿¬ À¯Âø ¹æÁöÁ¦

Á¦6Àå À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Á¦Á¦º°

  • ½ÃÀå ÇöȲ
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Á¦Á¦º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Á¦Á¦º°, ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
  • À¯Âø ¹æÁöÁ¦ ½ÃÀå ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Çʸ§ Á¦Á¦
    • °Ö Á¦Á¦
    • ¾×ü Á¦Á¦

Á¦7Àå À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : ¿ëµµº°, ÃßÁ¤°ú ¿¹Ãø, 2020-2030³â
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ºÎÀΰú ¼ö¼ú
    • ÀϹݿܰú/º¹ºÎ¿Ü°ú
    • Á¤Çü¿Ü°ú
    • ½ÉÇ÷°ü¿Ü°ú
    • ½Å°æ¿Ü°ú
    • ºñ´¢±â¿Ü°ú
    • Àç°Ç¿Ü°ú
    • ±âŸ

Á¦8Àå À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Áö¿ª ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • À¯Âø ¹æÁöÁ¦ ¼¼°è ½ÃÀå : Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´ÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ À¯Âø ¹æÁöÁ¦ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Baxter International Inc(US)
    • Johnson & Johnson(US)
    • Becton, Dickinson and Company(US)
    • Integra LifeSciences(US)
    • Anika Therapeutics Inc(US)
    • Atrium Medical Corporation(US)
    • MAST Biosurgery(Switzerland)
    • Innocoll Inc(Ireland)
    • Betatech Medical(Turkey)
    • CorMatrix Cardiovascular, Inc.(US)

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 24.02.27

Global Adhesion Barrier Market is valued at approximately USD 621.61 million in 2022 and is anticipated to grow with a healthy growth rate of more than 8.40% during the forecast period 2023-2030. Adhesion barriers are medical devices designed to prevent or reduce the formation of adhesions. Adhesions are fibrous bands of tissue that can form between organs and tissues, often as a result of surgery or trauma. These adhesions can cause organs or tissues to stick together, leading to complications such as pain, bowel obstruction, or fertility issues. Adhesion barriers aim to create a physical barrier between adjacent tissues to minimize the risk of adhesion formation. The key factors driving the market growth are the increase in the number of surgical procedures, the growing aging population, the growing prevalence of gynecological disorders, and the rising number of orthopedic surgeries, including joint replacement and ligament repair procedures that are anticipated to support the market growth during the forecast period 2023-2030.

Additionally, the growing number of surgical procedures is anticipated to support the market growth. As the number of surgical procedures continues to rise, the risk of postoperative adhesion formation also increases. More surgeries mean a greater demand for adhesion barriers to prevent complications associated with adhesions. According to Statista, in 2022, the number of surgical procedure units worldwide was 294.24 million and it is anticipated to reach 316.21 million by 2025. As a result, the rising surgical procedure is anticipated to support the market growth over the forecast period. Moreover, increasing healthcare expenditure, and rising awareness about adhesion-related complications are anticipated to create lucrative opportunities for the market over the forecast period 2023-2030. However, the stringent regulations and limited technological innovations stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Adhesion Barrier Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising number of surgical procedures, including abdominal, gynecological, and orthopedic surgeries, advances in adhesion barrier technologies, including the development of more effective and long-lasting barriers, and the presence of key market players. Whereas, the Asia Pacific is expected to grow with the highest CAGR over the forecast period, owing to factors such as the increasing surgical procedures, rising awareness of adhesion-related complications, rising incidence of chronic diseases, growing geriatric population, and increasing healthcare expenditure.

Major market player included in this report are:

  • Baxter International Inc (US)
  • Johnson & Johnson (US)
  • Becton, Dickinson and Company (US)
  • Integra LifeSciences (US)
  • Anika Therapeutics Inc (US)
  • Atrium Medical Corporation (US)
  • MAST Biosurgery (Switzerland)
  • Innocoll Inc (Ireland)
  • Betatech Medical (Turkey)
  • CorMatrix Cardiovascular, Inc. (US)

Recent Developments in the Market:

  • In June 2022, CGBIO introduced MEDICLORE, an innovative anti-adhesion agent, in Indonesia. This remarkable solution prevents adhesion by transitioning from a liquid to a gel state upon contact with the body's natural temperature when applied.

Global Adhesion Barrier Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Formulation, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Synthetic Adhesion Barriers
  • Natural Adhesion Barriers

By Formulation:

  • Film Formulations
  • Gel Formulations
  • Liquid Formulations

By Application:

  • Gynecological Surgeries
  • General/Abdominal Surgeries
  • Orthopedic Surgeries
  • Cardiovascular Surgeries
  • Neurological Surgeries
  • Urological Surgeries
  • Reconstructive Surgeries
  • Other

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Adhesion Barrier Market, by Region, 2020-2030 (USD Million)
    • 1.2.2. Adhesion Barrier Market, by Product, 2020-2030 (USD Million)
    • 1.2.3. Adhesion Barrier Market, by Formulation, 2020-2030 (USD Million)
    • 1.2.4. Adhesion Barrier Market, by Application, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Adhesion Barrier Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Adhesion Barrier Market Dynamics

  • 3.1. Adhesion Barrier Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in the number of surgical procedures
      • 3.1.1.2. Growing aging population
      • 3.1.1.3. Growing prevalence of gynecological disorders
      • 3.1.1.4. Rising number of orthopedic surgeries
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stringent regulations and limited technological innovations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing healthcare expenditure
      • 3.1.3.2. Rising awareness about adhesion-related complications

Chapter 4. Global Adhesion Barrier Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Adhesion Barrier Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Adhesion Barrier Market by Product, Performance - Potential Analysis
  • 5.3. Global Adhesion Barrier Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 5.4. Adhesion Barrier Market, Sub Segment Analysis
    • 5.4.1. Synthetic Adhesion Barriers
    • 5.4.2. Natural Adhesion Barriers

Chapter 6. Global Adhesion Barrier Market, by Formulation

  • 6.1. Market Snapshot
  • 6.2. Global Adhesion Barrier Market by Formulation, Performance - Potential Analysis
  • 6.3. Global Adhesion Barrier Market Estimates & Forecasts by Formulation 2020-2030 (USD Million)
  • 6.4. Adhesion Barrier Market, Sub Segment Analysis
    • 6.4.1. Film Formulations
    • 6.4.2. Gel Formulations
    • 6.4.3. Liquid Formulations

Chapter 7. Global Adhesion Barrier Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Adhesion Barrier Market by Application, Performance - Potential Analysis
  • 7.3. Global Adhesion Barrier Market Estimates & Forecasts by Application 2020-2030 (USD Million)
  • 7.4. Adhesion Barrier Market, Sub Segment Analysis
    • 7.4.1. Gynecological Surgeries
    • 7.4.2. General/Abdominal Surgeries
    • 7.4.3. Orthopedic Surgeries
    • 7.4.4. Cardiovascular Surgeries
    • 7.4.5. Neurological Surgeries
    • 7.4.6. Urological Surgeries
    • 7.4.7. Reconstructive Surgeries
    • 7.4.8. Other

Chapter 8. Global Adhesion Barrier Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Adhesion Barrier Market, Regional Market Snapshot
  • 8.4. North America Adhesion Barrier Market
    • 8.4.1. U.S. Adhesion Barrier Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Formulation breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Adhesion Barrier Market
  • 8.5. Europe Adhesion Barrier Market Snapshot
    • 8.5.1. U.K. Adhesion Barrier Market
    • 8.5.2. Germany Adhesion Barrier Market
    • 8.5.3. France Adhesion Barrier Market
    • 8.5.4. Spain Adhesion Barrier Market
    • 8.5.5. Italy Adhesion Barrier Market
    • 8.5.6. Rest of Europe Adhesion Barrier Market
  • 8.6. Asia-Pacific Adhesion Barrier Market Snapshot
    • 8.6.1. China Adhesion Barrier Market
    • 8.6.2. India Adhesion Barrier Market
    • 8.6.3. Japan Adhesion Barrier Market
    • 8.6.4. Australia Adhesion Barrier Market
    • 8.6.5. South Korea Adhesion Barrier Market
    • 8.6.6. Rest of Asia Pacific Adhesion Barrier Market
  • 8.7. Latin America Adhesion Barrier Market Snapshot
    • 8.7.1. Brazil Adhesion Barrier Market
    • 8.7.2. Mexico Adhesion Barrier Market
  • 8.8. Middle East & Africa Adhesion Barrier Market
    • 8.8.1. Saudi Arabia Adhesion Barrier Market
    • 8.8.2. South Africa Adhesion Barrier Market
    • 8.8.3. Rest of Middle East & Africa Adhesion Barrier Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Baxter International Inc (US)
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Johnson & Johnson (US)
    • 9.3.3. Becton, Dickinson and Company (US)
    • 9.3.4. Integra LifeSciences (US)
    • 9.3.5. Anika Therapeutics Inc (US)
    • 9.3.6. Atrium Medical Corporation (US)
    • 9.3.7. MAST Biosurgery (Switzerland)
    • 9.3.8. Innocoll Inc (Ireland)
    • 9.3.9. Betatech Medical (Turkey)
    • 9.3.10. CorMatrix Cardiovascular, Inc. (US)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦